Dow Down 1.40% Nasdaq Down 1.59%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
13.76 Down 1.01(6.84%) Oct 1, 4:00PM EDT
|After Hours : 13.86 Up 0.10 (0.73%) Oct 1, 6:15PM EDT
Prev Close:14.77
Open:14.69
Bid:13.77 x 1000
Ask:13.85 x 1500
1y Target Est:33.50
Beta:2.95
Earnings Date:Dec 15 - Dec 19 (Est.)
Day's Range:13.55 - 14.80
52wk Range:5.85 - 27.63
Volume:3,416,882
Avg Vol (3m):3,148,020
Market Cap:728.01M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ARWRDown 6.84%728.01M
APNT 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4,465.46
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-1.05
Quarterly EPS Est (Sep-14) :-0.24
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.79

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback